| 000 | 01733 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514231642.0 | ||
| 264 | 0 | _c20050819 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/JVI.79.13.7990-8003.2005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMajumder, Biswanath | |
| 245 | 0 | 0 |
_aHuman immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. _h[electronic resource] |
| 260 |
_bJournal of virology _cJul 2005 |
||
| 300 |
_a7990-8003 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntigens, CD _xgenetics |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 |
_aDendritic Cells _xcytology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGene Products, vpr _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _avpr Gene Products, Human Immunodeficiency Virus |
| 700 | 1 | _aJanket, Michelle L | |
| 700 | 1 | _aSchafer, Elizabeth A | |
| 700 | 1 | _aSchaubert, Keri | |
| 700 | 1 | _aHuang, Xiao-Li | |
| 700 | 1 | _aKan-Mitchell, June | |
| 700 | 1 | _aRinaldo, Charles R | |
| 700 | 1 | _aAyyavoo, Velpandi | |
| 773 | 0 |
_tJournal of virology _gvol. 79 _gno. 13 _gp. 7990-8003 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.79.13.7990-8003.2005 _zAvailable from publisher's website |
| 999 |
_c15615704 _d15615704 |
||